Status:

UNKNOWN

Outcome Analysis of Endoscopic Resection of Pituitary Adenomas

Lead Sponsor:

National Cheng-Kung University Hospital

Conditions:

Pituitary Adenoma

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The goal of this prospective study is to learn about the operative outcomes in patients with pituitary adenoma who receive endoscopic resection. The main question it aims to answer is: • What are th...

Eligibility Criteria

Inclusion

  • Adult patient
  • Pathological diagnosis of pituitary adenoma
  • Underwent endoscopic endonasal resection

Exclusion

  • Age \< 18 or \> 80 years
  • Non-pituitary adenoma pathologies
  • Underwent non-endoscopic surgery

Key Trial Info

Start Date :

January 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT06156020

Start Date

January 1 2020

End Date

December 1 2025

Last Update

March 21 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Cheng-Kung University Hospital

Tainan, Taiwan, 704

Outcome Analysis of Endoscopic Resection of Pituitary Adenomas | DecenTrialz